We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+42.64%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.46B
AUM Growth
+$256M
Cap. Flow
+$4.95B
Cap. Flow %
338.44%
Top 10 Hldgs %
14.04%
Holding
1,230
New
412
Increased
195
Reduced
230
Closed
293

Sector Composition

Rank Sector Weight
1 Technology 11.56%
2 Consumer Discretionary 8.68%
3 Healthcare 7.6%
4 Communication Services 6.73%
5 Industrials 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDSI
826
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$147K 0.01%
+33,770
New +$152K
FLR icon
827
Fluor
FLR
$7.01B
$144K 0.01%
+11,890
New +$125K
FTI icon
828
TechnipFMC
FTI
$28.1B
$142K 0.01%
27,821
+12,365
+80% +$72K
TS icon
829
Tenaris
TS
$28.9B
$142K 0.01%
+11,000
New +$145K
CVA
830
DELISTED
Covanta Holding Corporation
CVA
$139K 0.01%
+14,536
New +$124K
EMKR
831
DELISTED
Emcore Corp
EMKR
$139K 0.01%
+4,384
New +$124K
AMRX icon
832
Amneal Pharmaceuticals
AMRX
$5.85B
$137K 0.01%
28,875
+4,275
+17% +$17.6K
NSLR
833
Neostellar Capital Corp
NSLR
$269M
$137K 0.01%
+19,324
New +$109K
FREEW
834
DELISTED
Whole Earth Brands, Inc. Warrant
FREEW
$136K 0.01%
+16,799
New +$21.5K
DNOW icon
835
DNOW Inc
DNOW
$2.58B
$134K 0.01%
15,540
+740
+5% +$5.08K
MX icon
836
Magnachip Semiconductor
MX
$119M
$134K 0.01%
12,966
+146
+1% +$1.63K
NXGN
837
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$134K 0.01%
+12,170
New +$126K
ALACR
838
DELISTED
Alberton Acquisition Corp Rights
ALACR
$130K 0.01%
500,000
-249,300
-33% -$41.5K
ALT icon
839
Altimmune
ALT
$552M
$129K 0.01%
+12,011
New +$66K
DBVT
840
DBV Technologies
DBVT
$799M
$128K 0.01%
+2,910
New +$149K
HPE icon
841
Hewlett Packard
HPE
$63.4B
$128K 0.01%
+13,184
New +$129K
BLU
842
DELISTED
BELLUS Health Inc.
BLU
$126K 0.01%
+12,183
New +$123K
DMYT.WS
843
DELISTED
dMY Technology Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Clas
DMYT.WS
$125K 0.01%
+12,500
New +$10.5K
CTMX icon
844
CytomX Therapeutics
CTMX
$675M
$122K 0.01%
14,595
+695
+5% +$6.45K
ORSNR
845
DELISTED
Orisun Acquisition Corp. Right
ORSNR
$120K 0.01%
419,631
GPMT
846
Granite Point Mortgage Trust
GPMT
$69M
$117K 0.01%
+16,233
New +$88.1K
IFRX icon
847
InflaRx
IFRX
$250M
$117K 0.01%
25,444
-18,339
-42% -$119K
BCOV
848
DELISTED
Brightcove, Inc.
BCOV
$117K 0.01%
14,910
+710
+5% +$5.72K
EIGR
849
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$117K 0.01%
407
-6
-1% -$1.77K
IMGN
850
DELISTED
Immunogen Inc
IMGN
$117K 0.01%
25,410
+1,210
+5% +$5.15K

Similar funds

Boothbay Fund Management's Q2 2020 Portfolio in Review

As of Q2 2020, Boothbay Fund Management held 1,230 positions worth $1.46B, up 21% from $1.21B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boothbay Fund Management deployed $4.95B of net new capital in Q2 2020, opening 412 new positions and adding to 195 existing holdings. Its largest new stake was Tesla: 90,556,950 shares worth $25.6M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Sprott Physical Platinum and Palladium Trust, an estimated $11.4M trimmed.

  • Boothbay Fund Management's largest Q2 2020 buy was Tesla: 90,556,950 shares worth $25.6M.
  • Boothbay Fund Management added most to Alphabet (Google) Class C in Q2 2020, an estimated $27.1M increase.
  • Boothbay Fund Management's biggest Q2 2020 reduction was Sprott Physical Platinum and Palladium Trust, cutting an estimated $11.4M.
  • Boothbay Fund Management fully exited Allergan plc in Q2 2020, selling an estimated $46.4M.
  • Boothbay Fund Management's ten largest holdings make up 14% of its $1.46B portfolio in Q2 2020.
  • Boothbay Fund Management opened 412 new positions and closed 293 in Q2 2020.
  • Boothbay Fund Management's portfolio value rose 21% quarter-over-quarter to $1.46B.

Based on Boothbay Fund Management's 13F filing for Q2 2020, filed 14 Aug 2020.